- ►thelancet.com AC Keech, P Mitchell, PA Summanen, J O'Day, … - The Lancet, 2007 - Elsevier The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study was a
multinational randomised trial of 9795 patients aged 50–75 years with type 2
diabetes mellitus. Eligible patients were randomly assigned to receive ... Cited by 51 - Related articles - All 33 versions
- ►diabetesjournals.org J Shen, DK Arnett, LD Parnell, JM Peacock, … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—There were strong associations of m301G>A>T (rs3091244; P = 0.003),
i178T>A (rs1417938; P = 0.001), 3u1273C>T (rs1130864; P = 0.001), and 3u2131C>T
(rs1205; P < 0.001) with baseline CRP levels. Moreover, among subjects with ... Cited by 11 - Related articles - BL Direct - All 13 versions
JC Fruchart, F Sacks, MP Hermans, G … - The American Journal of Cardiology, 2008 - Elsevier Despite achieving targets for low-density lipoprotein (LDL) cholesterol, blood
pressure, and glycemia in accordance with current standards of care, patients
with dyslipidemia remain at high residual risk of vascular events. ... Cited by 13 - Related articles - All 7 versions
- ►dvdres.com [PDF] JC Fruchart, FM Sacks, MP Hermans, G … - Diabetes & Vascular Disease Research, 2008 - dvr.sagepub.com DOI: 10.3132/dvdr.2008.046 2008; 5; 319 Diab Vasc Dis Res Zambon and Paul Zimmet ... Jorge Plutzky, Zeljko Reiner, Robert S Rosenson, Bart Staels, Jane K Stock,
Rody Sy, Christoph Wanner, Alberto Chapman, Paul M Dodson, Paola Fioretto, ... Cited by 11 - Related articles - All 11 versions
- ►nursing2008.com RS Rosenson - American Heart Journal, 2008 - nursing2008.com This study was supported through a research grant to the University of Michigan
and Northwestern University from Abbott Laboratories, Inc. DiaDexus, Inc,
provided analyses of lipoprotein associated phospholipase A 2 mass for this ... Cited by 9 - Related articles - Cached - All 37 versions
- ►diabetesjournals.org R Scott, R O'Brien, G Fulcher, C Pardy, M d … - Diabetes Care, 2009 - Am Diabetes Assoc RESULTS—More than 80% of FIELD participants met the ATP III criteria for
metabolic syndrome. Each ATP III feature of metabolic syndrome, apart from
increased waist circumference, increased the absolute risk of CVD events ... Cited by 8 - Related articles - All 3 versions
- ►cardiovascres.org KK Koh, PC Oh, MJ Quon - Cardiovascular Research, 2009 - cardiovascres.oxfordjournals.org Chronic inflammation is a pathogenic feature of atherosclerosis and
cardiovascular disease mediated by substances including angiotensin II,
proinflammatory cytokines, and free fatty acids. This promotes generation ... Cited by 5 - Related articles - All 6 versions
- ►nutrition.org M Macias-Gonzalez, F Cardona, M Queipo- … - Journal of Nutrition, 2008 - Am Soc Nutrition PPAR is a transcriptional regulator of metabolism; its activity can be modulated
by direct binding of dietary lipids. The most prevalent human PPAR gene variant,
Ala12, is associated with postprandial hypertriglyceridemia in patients ... Cited by 5 - Related articles - All 3 versions
- ►aspetjournals.org YJ Chen, J Quilley - Journal of Pharmacology and Experimental …, 2008 - ASPET Renal cyclooxygenase (COX)-2 expression is increased in the diabetic rat and has
been linked to increased glomerular filtration rate (GFR) and renal injury. Our
studies indicate that oxidative stress in the form of peroxynitrite (ONOO) ... Cited by 4 - Related articles - All 5 versions
PM Dodson - Practical Diabetes International, 2008 - interscience.wiley.com While laser treatment is regarded as the standard therapy, intensive medical
management of glycaemia and hypertension is a priority to reduce the risk of
diabetic retinopathy. Recent data have prompted a re-evaluation of the role ... Cited by 3 - Related articles - BL Direct
